Clinical Trials Directory

Trials / Completed

CompletedNCT05558150

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

A Randomized, Open-label, Multiple-dose, Crossover Clinical Trial to Investigate the Pharmacokinetic Drug Interactions and Safety After Co-administration of Ilaprazole and Aceclofenac in Healthy Adults

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Il-Yang Pharm. Co., Ltd. · Industry
Sex
All
Age
19 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study evaluate the pharmacokinetic drug interactions and safety after co-administration of ilaprazole and Aceclofenac in healthy adults.

Conditions

Interventions

TypeNameDescription
DRUGIlaprazoleIlaprazole 10mg
DRUGAceclofenacAceclofenac 100mg

Timeline

Start date
2022-11-10
Primary completion
2022-12-14
Completion
2022-12-22
First posted
2022-09-28
Last updated
2023-06-28

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05558150. Inclusion in this directory is not an endorsement.